ImmunityBio Q3 Adj. EPS $(0.09) Misses $(0.08) Estimate, Sales $48.841M Miss $59.250M Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Misses
ImmunityBio (NASDAQ:IBRX) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 28.57 percent decrease over losses of $(0.07) per share from the
ImmunityBio (NASDAQ:IBRX) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 28.57 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $48.841 million which missed the analyst consensus estimate of $59.250 million by 17.57 percent. This is a 52.34 percent increase over sales of $32.061 million the same period last year.